Thermo Fisher Raises 2026 Guidance Following 10% Revenue Growth

Key Facts

1Thermo Fisher Scientific raised its 2026 revenue guidance to a range of $47.4 billion to $48.1 billion.

2The company reported a 10% year-over-year revenue increase to $11.99 billion for the second quarter.

3Goldman Sachs increased its price target for TMO to $780.00, maintaining a Buy rating.

Thermo Fisher Scientific raised its 2026 revenue guidance to a range of $47.4 billion to $48.1 billion, AD HOC NEWS reported. The company posted a 10% year-over-year increase in second-quarter revenue to $11.99 billion, while adjusted earnings per share rose 13% to $6.03 during the same period.

Goldman Sachs increased its price target for TMO to $780.00 with a Buy rating on September 21, 2026. TMO closed at $679.61 on September 29, 2026, having reached a session high of $681.38. Company management expects organic revenue growth of 4% in the second half of the year, supported by robust demand in the pharma and biotech sectors.